Tindak Tutur (Speech Act) dan Implikatur dalam Penggunaan Bahasa
Sinar Dunia: Jurnal Riset Sosial Humaniora dan Ilmu Pendidikan · 2022
DOI: 10.58192/sidu.v1i3.130 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sinar Dunia: Jurnal Riset Sosial Humaniora dan Ilmu Pendidikan, 2022. Verfasst von Paulana Christian Suryawin und 2 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Abstract (Originalsprache)
The language and context of speech cannot be separated from each other, the two intertwine in tandem and complement each other. The communication process uses language as a medium for conveying its message. Communicators (speakers), communicants (speakers), messages, and speech situations are necessary parts of communication that are expected to be smooth communication and the delivery of messages. The delivery of the message by the speaker becomes hampered when there is a misalignment of understanding received by the speaker. This is what pragmatics is trying to interpret. Pragmatics is the study of the relationship of language to its context. In a comprehensive understanding of language in communication will give birth to language functions that ultimately form a strong language character. It is presented in the article on speech acts and implicature in the use of language.
Zitieren
APA
Suryawin, P. C., Wijaya, M., & Isnaini, H. (2022). Tindak Tutur (Speech Act) dan Implikatur dalam Penggunaan Bahasa. Sinar Dunia: Jurnal Riset Sosial Humaniora dan Ilmu Pendidikan. https://doi.org/10.58192/sidu.v1i3.130
Vancouver
Suryawin PC, Wijaya M, Isnaini H. Tindak Tutur (Speech Act) dan Implikatur dalam Penggunaan Bahasa. Sinar Dunia: Jurnal Riset Sosial Humaniora dan Ilmu Pendidikan. 2022. doi:10.58192/sidu.v1i3.130
BibTeX
@article{Suryawin2022,
author = {Suryawin, Paulana Christian and Wijaya, Maryadi and Isnaini, Heri},
title = {Tindak Tutur (Speech Act) dan Implikatur dalam Penggunaan Bahasa},
journal = {Sinar Dunia: Jurnal Riset Sosial Humaniora dan Ilmu Pendidikan},
year = {2022},
doi = {10.58192/sidu.v1i3.130}
}
EUVIMED